tirzepatide off shortage list FDA says this weight loss drug is over, but patients worry about cost and availability Many of you that are

NIH.gov Diabetes, Obesity, and Metabolism

Easier to Consume

What affects tesamorelin before and after results

Brand-Name Pricing (2026) Mounjaro (Diabetes Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: On shortage list periodically Zepbound (Weight Loss Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: Limited, shortage issues Manufacturer Savings Cards: Eli Lilly offers savings card Reduces cost to $25-$50/month Requirements: Commercial insurance (not Medicare/Medicaid) Exclusions: Cash-pay patients ineligible Income limits: May apply For uninsured or underinsured patients, brand-name is unaffordable at $1,069/month

10.1021/jm049924d 44